Sectra AB
STO:SECT B
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Sectra AB
Cash & Cash Equivalents
Sectra AB
Cash & Cash Equivalents Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Cash & Cash Equivalents | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
Sectra AB
STO:SECT B
|
Cash & Cash Equivalents
kr1.4B
|
CAGR 3-Years
41%
|
CAGR 5-Years
30%
|
CAGR 10-Years
21%
|
|
|
RaySearch Laboratories AB (publ)
STO:RAY B
|
Cash & Cash Equivalents
kr407.3m
|
CAGR 3-Years
36%
|
CAGR 5-Years
19%
|
CAGR 10-Years
N/A
|
|
|
ContextVision AB
OSE:CONTX
|
Cash & Cash Equivalents
kr69.8m
|
CAGR 3-Years
19%
|
CAGR 5-Years
9%
|
CAGR 10-Years
7%
|
|
|
M
|
Mentice AB
STO:MNTC
|
Cash & Cash Equivalents
kr39.6m
|
CAGR 3-Years
-6%
|
CAGR 5-Years
-4%
|
CAGR 10-Years
N/A
|
|
|
O
|
Ortivus AB
STO:ORTI B
|
Cash & Cash Equivalents
kr8.9m
|
CAGR 3-Years
5%
|
CAGR 5-Years
-17%
|
CAGR 10-Years
N/A
|
|
|
i
|
iZafe Group AB
STO:IZAFE B
|
Cash & Cash Equivalents
kr1.7m
|
CAGR 3-Years
-1%
|
CAGR 5-Years
-8%
|
CAGR 10-Years
31%
|
|
Sectra AB
Glance View
Sectra AB, a Swedish firm with a storied history dating back to 1978, has carved its niche in the dynamic world of medical technology and cybersecurity. Initially making its mark as an innovator within secure communications, the company swiftly recognized the burgeoning potential within the healthcare sector. By blending their prowess in advanced imaging technology with secure data handling, Sectra has established itself as a leader in medical IT systems. Their primary business revolves around the development and delivery of Picture Archiving and Communication Systems (PACS) that streamline the management and storage of medical images. These systems not only enhance diagnostic capabilities but also improve operational efficiencies for healthcare providers. Sectra’s revenue model leans heavily on long-term contracts and service agreements with hospitals and healthcare facilities worldwide, ensuring a steady stream of repeat business. The integration of state-of-the-art cybersecurity measures into their offerings has further cemented their reputation in an industry where data privacy and integrity are paramount. Beyond healthcare, Sectra continues to leverage its expertise in secure communications to cater to governments and defense agencies, providing a diversified income stream. This strategic diversification allows Sectra to remain resilient against the cyclicality of single-market dependencies, securing its position as a robust player in both health and security sectors.
See Also
What is Sectra AB's Cash & Cash Equivalents?
Cash & Cash Equivalents
1.4B
SEK
Based on the financial report for Jan 31, 2026, Sectra AB's Cash & Cash Equivalents amounts to 1.4B SEK.
What is Sectra AB's Cash & Cash Equivalents growth rate?
Cash & Cash Equivalents CAGR 10Y
21%
Over the last year, the Cash & Cash Equivalents growth was 17%. The average annual Cash & Cash Equivalents growth rates for Sectra AB have been 41% over the past three years , 30% over the past five years , and 21% over the past ten years .